
Naloxone is a lifesaving antidote to an opioid overdose, but it may be priced too high for those most vulnerable to opioid-related death, a new study finds. Between 2014 and 2018, naloxone costs rose 500% for those without insurance, while out-of-pocket costs for the medication dropped 26% for people with insurance, the researchers reported. The… read on > read on >